The success of bevacizumab suggests that inhibiting the VEGF pathway is a promising antiangiogenic approach for the treatment of multiple types of solid gastrointestinal tumor. Inhibition of VEGF ...

Samantha Kelly is a freelance writer with a focus on consumer technology, AI, social media, Big Tech, emerging trends and how they impact our everyday lives. Her work has been featured on CNN ...

Medical advice, help and doctors with a tablet for healthcare, research and medicine planning. Communication, collaboration and men working in cardiology talking about surgery results on technology.

MaaT013 showed positive results in the phase 3 ARES trial, meeting its primary endpoint of GI-ORR at day 28 in patients with third-line GI-aGVHD. MaaT013 showed positive results in the phase 3 ARES ...

Provider Partners is a value-based care (VBC) company singularly focused on nursing homes, assisted living facilities (ALF), and personal-care homes. Provider Partners offers services in three lanes: ...

François Chollet, an influential AI researcher, is launching a new startup that aims to build frontier AI systems with novel designs. “We’re betting on a different path to build AI capable of ...

Wireless follow focus systems are a game-changer for filmmakers, offering more precise focus control and enabling smoother, more engaging video than traditional manual methods. If you’re just starting ...

Currently, between 60 million and 70 million Americans struggle with GI diseases, according to the American Gastroenterological Association. The suite will also be integrated with NextGen's other ...

Additionally, SCA Health physicians serve more than 1.43 million patients each year. SCA Health’s business lines include PE GI Solutions, a GI-focused ASC business. Per its website, this business line ...

The glycemic index (GI) is a value used to measure how much specific foods increase blood sugar levels. Foods are classified as low, medium, or high glycemic foods and ranked on a scale of 0–100.

In an internal memo published on Microsoft’s blog, Nadella said that Microsoft’s focus for the coming year will be “model-forward” applications that “reshape all application categories.” ...

GSK will acquire IDRx, a Boston, MA–based biopharmaceutical company that specializes in developing therapeutics for gastrointestinal stromal tumors (GIST), a rare soft tissue sarcoma often caused by ...